Bochenek Tomasz, Sowula Patrycja, Rodak Małgorzata, Rybicka-Musialik Anna, Gruchlik Bartosz, Mizia-Stec Katarzyna
First Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, 40055 Katowice, Poland.
Upper-Silesian Medical Center, 40635 Katowice, Poland.
J Clin Med. 2023 Feb 16;12(4):1567. doi: 10.3390/jcm12041567.
We aimed to evaluate the rate and risk factors of in-hospital mortality in patients undergoing coronary angiography/angioplasty with IABP use as support. We included 214 patients (mean age: 67.5 ± 7.5 years, M/F: 143/71) with an IABP used as the periprocedural support between 2012 and 2020. The main indications for an IABP were cardiogenic shock (143 pts; 66.8%: 55 survivors (51.9%)/88 non-survivors (81.5%); < 0.001) and infarction with an initial significant impairment of ventricular function (34 pts; 15.9%: 21 (19.8%)/13 (12%); = 0.12). In-hospital death was the endpoint of this study. In-hospital death occurred in 108 (50.5%, M/F: 69.4%/30.6%) patients. The mean hospitalization time was 7 days (2-13); deaths occurred more frequently on the first day after the procedure (1 (1-3 days) vs. 3 (1-8), < 0.001); and the mean hospitalization time was 2 days (1-6) for non-survivors vs. 11 days (7-17) for survivors ( < 0.001). Regarding the patients who did not survive, they were older (69 vs. 66.5, = 0.043), their LVEF was lower (0-15%: 15 (13.9%) vs. 12 (11.3%); 16-40%: 73 (67.6%) vs. 65 (61.3%); >40%: 14 (13%) vs. 29 (27.4%); = 0.007), and hyperlipidemia was less common (30 (27.8%) vs. 55 (51.9%) pts, = 0.001) than in those who survived. The IABP is still a method for cardiac support; however, mortality limits its use.
我们旨在评估以主动脉内球囊反搏（IABP）作为支持进行冠状动脉造影/血管成形术患者的院内死亡率及危险因素。我们纳入了2012年至2020年间214例（平均年龄：67.5±7.5岁，男/女：143/71）将IABP用作围手术期支持的患者。IABP的主要适应证为心源性休克（143例患者；66.8%：55例存活者（51.9%）/88例非存活者（81.5%）；P<0.001）以及初始心室功能严重受损的梗死（34例患者；15.9%：21例（19.8%）/13例（12%）；P = 0.12）。院内死亡是本研究的终点。108例（50.5%，男/女：69.4%/30.6%）患者发生院内死亡。平均住院时间为7天（2 - 13天）；死亡更频繁地发生在术后第一天（1例（1 - 3天）对3例（1 - 8天），P<0.001）；非存活者的平均住院时间为2天（1 - 6天），而存活者为11天（7 - 17天）（P<0.001）。对于未存活的患者，他们年龄更大（69岁对66.5岁，P = 0.043），左心室射血分数（LVEF）更低（0 - 15%：15例（13.9%）对12例（11.3%）；16 - 40%：73例（67.6%）对65例（61.3%）；>40%：14例（13%）对29例（27.4%）；P = 0.007），且高脂血症比存活者更少见（30例（27.8%）对55例（51.9%）患者，P = 0.001）。IABP仍是一种心脏支持方法；然而，死亡率限制了其应用。
